702 Results

People

  1. Motzer
    Motzer
  2. Livingston
    Livingston
  3. Norton
    Norton
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Krown
    Krown
  7. Sepkowitz
    Sepkowitz
  8. O'Reilly
    O'Reilly
  9. Panageas
    Panageas
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)
  7. Epidemiology and Biostatistics (73)
  8. GSK Faculty (73)
  9. Division of Subspecialty Medicine (65)
  10. Gastrointestinal Oncology Service (64)
  1. "fever"
Formats
  1. Journal Article (657)
  2. Review (23)
  3. Conference Paper (6)
  4. Research Letter (6)
  5. Guidelines (5)
  6. Editorial (4)
  7. Correspondence (1)
Groups
  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)

More Groups

People
  1. Robert Motzer (24)
  2. Larry Norton (20)
  3. Philip Livingston (19)
  4. Carol Aghajanian (17)
  5. Clifford Hudis (17)
  6. Kent Sepkowitz (17)

More People

Years
  1. 2025 (21)
  2. 2024 (42)
  3. 2023 (40)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (44)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Clinical Cancer Research (33)
  3. Blood (22)
  4. Lancet Oncology (22)
  5. Cancer (21)
  6. New England Journal of Medicine (18)

More Publications

Publishers
  1. Elsevier Inc. (107)
  2. American Society of Clinical Oncology (70)
  3. Elsevier Science, Inc. (55)
  4. Springer (53)
  5. Nature Publishing Group (40)
  6. Wiley Blackwell (38)

More Publishers

Results (702)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Perelshteyn, A.; Jarnagin, W. R.; Schattner, M.; Gerdes, H.; Capanu, M.; Tang, L. H.; Lavalle, J.; Winston, C.; DeMatteo, R. P.; more...
    Annals of Surgery (2014)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial
    Journal Article

    Kwon, E. D.; Drake, C. G.; Scher, H. I.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Krainer, M.; Houede, N.; Santos, R.; Mahammedi, H.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
    Journal Article

    Korde, N.; Carlsten, M.; Lee, M. J.; Minter, A.; Tan, E.; Kwok, M.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • How I treat the peripheral T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Lunning, M. A.; Horwitz, S. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
    Journal Article

    Dhodapkar, M. V.; Sznol, M.; Zhao, B.; Wang, D.; Carvajal, R. D.; Keohan, M. L.; Chuang, E.; Sanborn, R. E.; Lutzky, J.; Powderly, J.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
    Journal Article

    Coutre, S. E.; Othus, M.; Powell, B.; Willman, C. L.; Stock, W.; Paietta, E.; Levitan, D.; Wetzler, M.; Attar, E. C.; Altman, J. K.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
    Journal Article

    Furman, R. R.; Sharman, J. P.; Coutre, S. E.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
    Journal Article

    Baselga, J.; Manikhas, A.; CorteĢs, J.; Llombart, A.; Roman, L.; Semiglazov, V. F.; Byakhov, M.; Lokanatha, D.; Forenza, S.; Goldfarb, R. H.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save